Clal Biotechnology Industries is a life sciences investment company. CBI is focused on identifying and supporting promising innovative ventures, developing proprietary solutions, addressing unmet medical needs with multibillion-dollar market potential. Clal Biotechnology Industries provides its companies access to the global biotechnology industry. Clal Biotechnology Industries invests in companies ranging from seed to maturity, both public and private. It applies diverse models of strategic cooperation, providing significant investments together with hands-on leadership and guidance. CBIs investments range from biotech and pharma to diagnostics and medical devices. Its team maximizes the value of existing investments, contributes to the development of investee companies and finds new investments and business opportunities with great potential returns in Israel and the United States. CBI's stockholders are Clal Industries, which holds a portfolio of investments from heavy industry to biotechnology, hi-tech and energy companies. Clal Industries is fully owned by Access Industries, a privately-held industrial group with long-term holdings in the sectors of natural resources and chemical, media and telecommunications, venture capital and real estate